1,506
Views
29
CrossRef citations to date
0
Altmetric
Research Paper

Sources to variability in circulating human miRNA signatures

, ORCID Icon, , , , , & show all
Pages 1791-1798 | Received 06 Apr 2017, Accepted 11 Aug 2017, Published online: 13 Sep 2017

References

  • Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.
  • Ambros, V.microRNAs: tiny regulators with great potential. Cell. 2001;107(7):823–6. doi:10.1016/S0092-8674(01)00616-X.
  • Leidinger, P., Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stähler C, et al., A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013;14(7):R78. doi:10.1186/gb-2013-14-7-r78.
  • Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP, Meese E. miRNAs in lung cancer – studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer. 2009;9:353. doi:10.1186/1471-2407-9-353.
  • Leidinger P, Brefort T, Backes C, Krapp M, Galata V, Beier M, Kohlhaas J, Huwer H, Meese E, Keller A. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Oncotarget. 2016;7(4):4611–23. doi:10.18632/oncotarget.6566.
  • Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richter P. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br J Cancer. 2017;117(2):266–273. doi:10.1038/bjc.2017.190.
  • Qu K, Zhang X, Lin T, Liu T, Wang Z, Liu S, Zhou L, Wei J, Chang H, Li K, et al. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation. Sci Rep. 2017;7(1):1692. doi:10.1038/s41598-017-01904-z.
  • Xing W, Zeng C. A novel serum microRNA-based identification and classification biomarker of human glioma. Tumour Biol. 2017;39(5):1010428317705339. doi:10.1177/1010428317705339
  • Ames H, Halushka MK, Rodriguez FJ. miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications. J Neuropathol Exp Neurol. 2017;76(4):246–254. doi:10.1093/jnen/nlx005.
  • Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, et al. Toward the blood-borne miRNome of human diseases. Nat Methods. 2011;8(10):841–3. doi:10.1038/nmeth.1682.
  • Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, Cheo D, D'Andrade P, DeMayo M, Dennis L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11(8):809–15. doi:10.1038/nmeth.3014.
  • Keller A, Meese E. Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings? Wiley Interdiscip Rev RNA. 2016;7(2):148–56.
  • Backes C, Meese E, Keller A. Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects. Mol Diagn Ther. 2016;20(6):509–518. doi:10.1007/s40291-016-0221-4.
  • Witwer KW, Halushka MK. Toward the promise of microRNAs – Enhancing reproducibility and rigor in microRNA research. RNA Biol. 2016;13(11):1103–1116. doi:10.1080/15476286.2016.1236172.
  • Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick R et al. miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med. 2014;12:224. doi:10.1186/s12916-014-0224-0.
  • Halushka MK. MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome. J Heart Lung Transplant. 2016;35(4):543. doi:10.1016/j.healun.2016.01.008.
  • Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res. 2014;42(12):7528–38. doi:10.1093/nar/gku461.
  • Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, Rheinheimer S, Meder B, Stähler C, Meese E, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44(8):3865–77. doi:10.1093/nar/gkw116.
  • Schwarz EC, Backes C, Knörck A, Ludwig N, Leidinger P, Hoxha C, Schwär G, Grossmann T, Müller SC, Hart M, et al. Deep characterization of blood cell miRNomes by NGS. Cell Mol Life Sci. 2016;73(16):3169–81. doi:10.1007/s00018-016-2154-9.
  • Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18(3):371–90. doi:10.1111/jcmm.12236.
  • Meder B, Backes C, Haas J, Leidinger P, Stähler C, Großmann T, Vogel B, Frese K, Giannitsis E, Katus HA, et al. Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin Chem. 2014;60(9):1200–8. doi:10.1373/clinchem.2014.224238.
  • Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, Kaluza D, Tréguer K, Carmona G, Bonauer A, et al. MicroRNA-34a regulates cardiac ageing and function. Nature. 2013;495(7439):107–10. doi:10.1038/nature11919.
  • Backes C, Sedaghat-Hamedani F, Frese K, Hart M, Ludwig N, Meder B, Meese E, Keller A. Bias in High-Throughput Analysis of miRNAs and Implications for Biomarker Studies. Anal Chem. 2016;88(4):2088–95. doi:10.1021/acs.analchem.5b03376.
  • Backes C, Khaleeq QT, Meese E, Keller A. miEAA: microRNA enrichment analysis and annotation. Nucleic Acids Res. 2016;44(W1):W110–W116. doi:10.1093/nar/gkw345
  • Backes C, Leidinger P, Altmann G, Wuerstle M, Meder B, Galata V, Mueller SC, Sickert D, Stähler C, Meese E, et al. Influence of next-generation sequencing and storage conditions on miRNA patterns generated from PAXgene blood. Anal Chem. 2015;87(17):8910–6. doi:10.1021/acs.analchem.5b02043.
  • Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol. 2011;8(3):506–16. doi:10.4161/rna.8.3.14994.
  • Rounge TB, Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE. microRNA Biomarker Discovery and High-Throughput DNA Sequencing Are Possible Using Long-term Archived Serum Samples. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1381–7. doi:10.1158/1055-9965.EPI-15-0289.
  • Balzano F, Balzano F, Deiana M, Dei Giudici S, Oggiano A, Baralla A, Pasella S, Mannu A, Pescatori M, Porcu B, Fanciulli G, et al. miRNA Stability in Frozen Plasma Samples. Molecules. 2015;20(10):19030–40. doi:10.3390/molecules201019030.
  • Ameling S, Kacprowski T, Chilukoti RK, Malsch C, Liebscher V, Suhre K, Pietzner M, Friedrich N, Homuth G, Hammer E, et al. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. BMC Med Genomics. 2015;8:61. doi:10.1186/s12920-015-0136-7.
  • Langseth H, et al. Cohort Profile: The Janus Serum Bank Cohort in Norway. Int J Epidemiol. 2016;46(2):403–404g. doi:10.1093/ije/dyw027.
  • Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–10. doi:10.1093/nar/30.1.207.
  • Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41( Database issue):D991–5. doi:10.1093/nar/gks1193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.